Antiviral strategies for emerging infectious diseases: Cayman Chemical
The emergence and global spread of SARS-CoV-2 has prompted scientific study on an unprecedented scale,…
Browsing: Vaccine Production
COVID-19: updates on vaccines and therapeutics
Take a look at our day-by-day updates covering the latest on therapeutics and vaccines for COVID-19, from new partnerships to clinical trials..
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
ECCMID19: Immune response to Ebola 2 years post-infection could provide clues for vaccine development
Two years after Ebola infection, survivors exhibit specific memory T cell responses against ebolavirus, according to new research presented at ECCMID.
Phase III study of Novavax’s RSV vaccine fails primary objective: March’s industry headlines
Take a look at this month’s industry headlines including news on Sanofi’s Dengvaxia® vaccine from the USA and the Philippines, clinical trial results for RSV vaccines and HIV injectables and new acquisitions for Merck.
Developing a maternal vaccine against respiratory syncytial virus
Recently, many programs developing respiratory syncytial virus vaccines have sought to vaccinate pregnant women in an effort to enhance maternal immunity. Find out about the challenges and the latest developments.
Ethically possible and ethically required: The path towards equitable inclusion of pregnant women in vaccine development
Vaccination during pregnancy provides important benefits, so why are pregnant women excluded from clinical trials? Learn more about the path towards including this group in vaccine development for both routine and emergency vaccinations.
Micromotor formulation shows promise for oral vaccination
A biomimetic, micromotor vaccine formulation has shown promising results in immunizing against Staphylococcus aureus in mouse models.
Freeze-dried polio vaccine could avoid cold chain issues
Researchers have developed a freeze-dried polio vaccine that doesn’t require refrigeration and is still efficacious after rehydration.
Merck cuts back on rotavirus vaccine commitment to West Africa: November’s industry headlines
Positive results for zoliflodacin, EMA approval for fexinidazole and Merck cuts rotavirus commitment – take a look a the month’s industry headlines.
